This reveals the potential role of the TGF-β-SMA4 signaling pathway in the malignancy-associated modulation of TIME and stimulates further discovery of the diagnostic and prognostic role of STAT6 and SMAD4 in thyroid tumors. The gene discussed is STAT6; the disease is thyroid tumor.